Quick Answer
Mosaic ImmunoEngineering Inc. reported Research And Development Expense of $183.9 thousand for the year ending 2024.
- Mosaic ImmunoEngineering Inc. showed a decrease of -57.8% in Research And Development Expense from 2023 to 2024.
- This data is from Mosaic ImmunoEngineering Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $230.5 thousand | Q4 2010: $157.5 thousand | Q3 2011: $170.2 thousand | Q4 2011: $150.8 thousand | Q1 2020: $0.00 | Q2 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $83.5 thousand | Q3 2020: $220.1 thousand | Q4 2020: $252.1 thousand | Q1 2021: $246.1 thousand | Q2 2021: $376.8 thousand | Q3 2021: $439.9 thousand | Q1 2022: $327.7 thousand | Q2 2022: $302.7 thousand | Q3 2022: $211.1 thousand | Q1 2023: $177.9 thousand | Q2 2023: $122.6 thousand | Q3 2023: $84.9 thousand | Q1 2024: $67.3 thousand | Q2 2024: $60.7 thousand | Q3 2024: $39.6 thousand | Q1 2025: $15.8 thousand | Q2 2025: $16.0 thousand | Q3 2025: $16.0 thousand.
- Over the full 4 years of available data (2021 to 2024), Mosaic ImmunoEngineering Inc.'s Research And Development Expense has declined by 87.4%.
- Historical annual values: Fiscal year 2024: $183.9 thousand | Fiscal year 2023: $435.4 thousand | Fiscal year 2022: $1.05 million | Fiscal year 2021: $1.46 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: